Growth hormone, vascular reactivity, and heart failure

European Journal of Clinical Pharmacology

Volumn 62, Issue 1, 2006, Pages 141-144

  Napoli, Raffaele ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Endothelial dysfunction; Growth hormone; Heart failure

Indexed keywords

CYTOKINE; GROWTH HORMONE; SOMATOMEDIN C; ACETYLCHOLINE;

BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GROWTH HORMONE DEFICIENCY; HEART FAILURE; HEART OUTPUT; HUMAN; PRIORITY JOURNAL; DRUG BLOOD LEVEL; DRUG MECHANISM; LONG TERM CARE; VASCULAR DISEASE;

EID: 33344457950     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0016-8     Document Type: Conference Paper

References (28)

1. Saccà L, Napoli R, Cittadini A (2003) Growth hormone, acromegaly, and heart failure: an intricate triangulation. Clin Endocrinol 59:660-671
2. Rosen T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288
3. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG (1992) Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 340:1188-1192
4. Böger RH, Skamira C, Bode-Böger SM, Brabant G, von zur Mühlen A, Frölieh JC (1996) Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. J Clin Invest 98:2706-2713
5. Capaldo B, Guardasole V, Pardo F, Matarazzo M, Di Rella F, Numis F, Merola B, Longobardi S, Saccà L (2001) Abnormal vascular reactivity in growth hormone deficiency. Circulation 103:520-524
6. Celermajer DS (1997) Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 30:325-333
7. Nakamura M (1997) Peripheral vascular remodeling in chronic heart failure: clinical relevance and new conceptualization of its mechanisms. J Card Fail 5:127-138
8. Kats SD (1997) Mechanisms and implications of endothelial dysfunction in congestive heart failure. Curr Opin Cardiol 12:259-264
9. Harrington D, Coats AJS (1997) Mechanisms of exercise intolerance in congestive heart failure. Curr Opin Cardiol 12:224-232
10. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM (1991) Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84:1589-1596
11. Drexler H, Hayoz D, Munzel T, Burckardt H, Just H, Brunner HR, Zelis R (1992) Endothelial function in chronic congestive heart failure. Am J Cardiol 69:1596-1601
12. Saccà L, Cittadini A, Fazio S (1994) Growth hormone and the heart. Endocr Rev 15:555-573
13. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, Pardo F, Biondi B, Saccà L (1996) A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 334:809-814
14. Genth-Zotz S, Zotz R, Geil S, Voigtländer T, Meyer J, Darius H (1999) Recombinant growth hormone therapy in patients with ischemic cardiomyopathy. Effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. Circulation 99:18-21
15. Napoli R, Guardasole V, Matarazzo M, Palmieri EA, Oliviero U, Fazio S, Saccà L (2002) Growth hormone corrects vascular dysfunction in patients with chronic heart failure. J Am Coll Cardiol 39:90-95
16. Adamopoulos S, Parissis JT, Paraskevaidis I, Karatzas D, Livanis E, Georgiadis M, Karavolias G, Mitropoulos D, Gegiannis D, Kremastinos DT (2003) Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur Heart J 24:2186-2196
17. Volterrani M, Desenzani P, Lorusso R, d'Aloia A, Manelli F, Giustina A (1997) Hemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet 349:1067-1068
18. Osterziel KJ, Strohm O, Schuler J, Friederich M, Hänlein D, Willenbrock R, Anker SD, Poole-Wilson PA, Ranke MB, Dietz R (1998) Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 351:1233-1237
19. Isgaard J, Bergrowth CH, Caidahal K, Lomsky M, Hjalmarson A, Bengtsoon BA (1998) A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur Heart J 19:1704-1711
20. Johansson JO, Wiren L, Oscarsson J, Bengtsson BA, Johannsson G (2003) Growth hormone replacement in GH-deficient adults: a crossover trial comparing the effect on metabolic control, well-being and compliance of three injections per week versus daily injections. Growth Horm IGF Res 13:306-315
21. Perrot A, Ranke MB, Dietz R, Osterziel KJ (2001) Growth hormone treatment in dilated cardiomyopathy. J Card Surg 16:127-131
22. Osterziel KJ, Ranke MB, Strohm O, Dietz R (2000) The somatotrophic system in patients with dilated cardiomyopathy: relation of insulin-like growth factor-1 and alterations during growth hormone therapy to cardiac function. Clin Endocrinol 53:61-68
23. Osterziel KJ, Blum WF, Strohm O, Dietz R (2000) The severity of chronic heart failure due to coronary artery disease predicts the endocrine effects of short-term growth hormone administration. J Clin Endocrinol Metab 85:1533-1539
24. Anker SD, Volterrani M, Pflaum CD, Strasburger CJ, Osterziel KJ, Doehner W, Ranke MB, Poole-Wilson PA, Giustina A, Dietz R, Coats AJ (2001) Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol 38:443-452
25. Osterziel KJ, Bode-Böger SM, Strohm O, Ellmer AE, Bit-Avragim N, Hänlein D, Ranke MB, Dietz R, Böger RH (2000) Role of nitric oxide in the vasodilator effect of recombinant human growth hormone in patients with dilated cardiomyopathy. Cardiovasc Res 45:447-453
26. G-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF-I. Possible role of nitric oxide in muscle protein synthesis. J Clin Invest 97:1319-1328
27. Napoli R, Guardasole V, Angelini V, D'Amico F, Zarra E, Matarazzo M, Saccà L (2003) Acute effects of growth hormone on vascular function in human subjects. J Clin Endocrinol Metab 88:2817-2820
28. Thum T, Tsikas D, Frölich JC, Borlak J (2003) Growth hormone induces eNOS expression and nitric oxide release in a cultured human endothelial cell line. FEBS Lett 555:567-571